Akara Hyaluronate Kwadoro Jiri na Viscosupplementation
Supartz, ihe ngwọta nke hyaluronate sodium, bụ otu n'ime hyaluronates eji mee ihe na viscosupmentation . A na-agbanye Supartz ozugbo n'ime ikpo ụkwụ ikpere iji weghachite ngwongwo na lubricating properties nke mmiri synovial (ntụgharị, mmiri njikọ). E ji hyaluronate sodium nke e ji mee ihe na Supartz si na combs. Hyaluronate sodium bụ polysaccharide bụ nke nwere mkpụrụedemede glucuronic acid na N-acetylglucosamine .
Nkwado nke Supartz na Tụlee Fx
FDA United States kwadoro Supartz na Jenụwarị 24, 2001 maka ọgwụgwọ osteoarthritia ikpere na ndị ọrịa bụ ndị na-enwetaghị ahụike zuru ezu na ọgwụgwọ na-agbanwe agbanwe, gụnyere mmega ahụ, ọgwụgwọ ahụike, ọgwụ mgbu , ihe enyemaka ndị njem , na ngwugwu ọkụ ma ọ bụ oyi . A na-enyocha nkwonkwo ndị ọzọ. A na-eji Supartz na Japan ebe ọ bụ n'afọ 1987. A na-agbanye ya otu ugboro n'izu maka izu ise n'izu. Ụfọdụ ndị ọrịa nwere ike ịza ezigbo ihe mgbe izu 3 gasịrị.
N'October 12, 2015, Bioventus, onye na-eme Supartz, kwupụtara ọkwa nke Supartz Fx (10 mg sodium hyaluronate nke na-agbaze n'ime saline 1.0%), nke nwere aha agbasapụ site na mbụ Supartz, na-enye ohere iji meegharị usoro mgbachi. Ọ bụ ezie na etinyere nchedo nchekwa maka usoro ogwu ozo, enweghi ike ịmalite imeghari usoro ihe omume.
Ịdọ aka ná ntị na nchebe
Supartz ekwesịghị inye onye ọrịa ọ bụla na hypersensitivity mara na ngwaahịa sodium hyaluronate.
E kwesịrị iji nlezianya mee ihe mgbe ị na-emeso ndị ọrịa nwere ọrịa ahụ maara nke ọma na proteins, eggs, or feathers. Ndị ọrịa na-arịa ọrịa ma ọ bụ ọrịa anụahụ na mpaghara ebe a ga-enye ya ọgwụ ahụ ekwesịghị isi na Supherz.
Enweghị nchekwa na ịdị irè nke Supartz enwebeghị ike n'ime ndị inyom dị ime, ma ọ bụ ịkwa ụmụ nwanyị.
Ejibeghị ya mee ihe na ụmụaka.
Mmetụta Na-agakarị
Mmetụta mmetụta nkịtị ma ọ bụ mmejọ ndị metụtara Supartz gụnyere:
- Ihe mgbu na nkwonkwo na-enweghị mmetụ
- Mgbu azụ
- Ihe mgbu na-abụghị nke a
- Ngwunye site na mmegharị
- A isi ọwụwa
Mgbu ma ọ bụ ihe mgbu, nke bụ transient, nwere ike ime na nkwonkwo nke agbara ya na Supartz. A gwara ndị ọrịa ka ha zere ihe ndị siri ike ma ọ bụ ibu arọ n'ime awa 48 na-esote ọgbụgba.
Ndabere ala
Nnyocha nke 5 nchịkọta ahụike nke ọma gosipụtara ọhụụ dị iche n'etiti Supartz na ndị na-achịkwa otu dị iche iche n'ihe gbasara ihe ọjọọ. Ọ bụ ezie na nchekwa nke Supartz na nlezianya ndị ọzọ ejiriwo nlezianya kwadoro ya, arụrịta ụka dị irè. Banyere irè, otu Cochrane Review kwubiri na viscosupmentation dị irè karịa placebo, ma e nwere ihe ọmụmụ ndị ọzọ dabara adabere na nhụta ahụ na-enye ihe enyemaka dị egwu.
Isi mmalite:
Tụlee Fx. Na-edepụta Ozi. Ndị na-anwụ anwụ. http://www.supartzfx.com/wp-content/uploads/2015/07/SUPARTZ_FX_Package_Insert.pdf
Ndị na-emepụta ihe ndị na-emepụta ihe ndị ọzọ na-eme ka ha nwee ike ịgbakwunye Fx Ugbu a, na-eme ka ọtụtụ ndị na-ahụ maka nchebe na-aga n'ihu. October 12, 2015.
http://www.bioventusglobal.com/news/press-releases/bioventus-launches-supartz-fx%E2%84%A2-now-expanded-safety-label-repeat-injection-cycles
Hyaluronic acid (Supartz): nyochaa iji ya na ọrịa ogbu na nkwonkwo. Kọmitii Curan. Ọgwụ ọjọọ. November 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20964466